Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$16.5 - $29.7 $3.68 Million - $6.62 Million
-222,776 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$13.68 - $34.6 $8.57 Million - $21.7 Million
-626,702 Reduced 73.77%
222,776 $3.97 Million
Q4 2019

Feb 14, 2020

SELL
$21.11 - $34.86 $583,522 - $963,600
-27,642 Reduced 3.15%
849,478 $28.3 Million
Q3 2019

Nov 14, 2019

SELL
$23.83 - $36.44 $3.26 Million - $4.99 Million
-136,958 Reduced 13.51%
877,120 $20.9 Million
Q2 2019

Aug 14, 2019

BUY
$32.75 - $40.35 $890,800 - $1.1 Million
27,200 Added 2.76%
1,014,078 $36.4 Million
Q1 2019

May 15, 2019

BUY
$35.47 - $54.55 $18.6 Million - $28.6 Million
525,200 Added 113.76%
986,878 $36.5 Million
Q4 2018

Feb 14, 2019

BUY
$38.35 - $50.39 $4.98 Million - $6.54 Million
129,778 Added 39.1%
461,678 $19.9 Million
Q2 2018

Aug 14, 2018

SELL
$48.35 - $65.33 $2.17 Million - $2.93 Million
-44,923 Reduced 11.92%
331,900 $16.5 Million
Q1 2018

May 15, 2018

SELL
$38.64 - $57.54 $891,695 - $1.33 Million
-23,077 Reduced 5.77%
376,823 $18.7 Million
Q4 2017

Feb 14, 2018

SELL
$27.28 - $43.26 $275,528 - $436,926
-10,100 Reduced 2.46%
399,900 $14.9 Million
Q3 2017

Nov 14, 2017

BUY
$17.15 - $32.72 $7.03 Million - $13.4 Million
410,000
410,000 $12.9 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $373M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Highline Capital Management, L.P. Portfolio

Follow Highline Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highline Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highline Capital Management, L.P. with notifications on news.